Hologram QSAR Studies of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides Derivatives as Selective Peripheral Benzodiazepine Receptor Ligands

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 2, 2010-02 ,pp. : 133-138

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 815-829

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, benzodiazepine receptor affinity and in vivo testing of 3-aryl-4,7-dihydro-6-(N 1 '-alkylpyrazol-3'- or 5'-yl)pyrazolo[1,5-a]pyrimidin-7-ones

By Selleri S.   Bruni F.   Costanzo A.   Guerrini G.   Casilli M.   Costagli C.   Giusti L.   Lucacchini A.   Martini C.   Aiello P.M.   Lamberti C.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 12, 1998-12 ,pp. : 941-953

Elsevier

Access to resources Recommend Favorite

Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats

By Abe K.   Takeyama C.   Yoshimura K.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 145-152

Elsevier

Access to resources Recommend Favorite

The effects of the novel benzodiazepine receptor inverse agonist Ru 34000 on ethanol-maintained behaviors

By June H.L.   Eggers M.W.   Warren-Reese C.   DeLong J.   Ricks-Cord A.   Durr L.F.   Cason C.R.  

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 151-158

Elsevier

Access to resources Recommend Favorite